Agilus Diagnostics

What Agilus Diagnostics does

Agilus Diagnostics Limited, formerly SRL Diagnostics, is a wholly owned subsidiary of Fortis Healthcare and operates India's largest diagnostic laboratory network by number of laboratories, with 413 networking labs spanning 30+ states and union territories. Founded in 1995 and rebranded in 2023, Agilus runs the country's broadest accredited diagnostic footprint, including 40+ NABL-accredited labs and 2 CAP-accredited labs, and was the first Indian diagnostic chain to achieve both NABL (1999) and CAP (2002) accreditation.

The company offers more than 3,600 routine and specialized tests across pathology, radiology, molecular diagnostics, genetics, and immunology, delivered through walk-in labs, a pan-India home sample collection network, a franchise collection center program (Abhinandan), and digital channels including a mobile app and WhatsApp booking. Technology capabilities include the Illumina NovaSeq X next-generation sequencing platform at its Mumbai global reference laboratory and a partnership with Lucence for LiquidHALLMARK liquid biopsy-based cancer molecular testing. Service portfolio spans routine blood tests, advanced panels, imaging (X-ray, ultrasound, ECG, echocardiogram, mammography), and preventive health packages (Vital Care, Active Care, Premium Care, etc.).

Agilus operates on a fee-for-service, per-test pricing model with publicly listed test prices, serving individual consumers (direct-to-consumer via website/app/WhatsApp/home collection), hospitals and clinics (B2B referrals, primarily Fortis Healthcare), corporate wellness clients, and franchise partner operators. Revenue is transactional with no subscription model; pricing ranges from ₹350 (CBC) to ₹12,000+ for specialty panels, with package discounts and same-day routine test turnaround. Go-to-market combines direct-to-consumer digital acquisition, institutional field sales to hospitals and corporates, and franchise-led decentralized expansion, all integrated within Fortis Healthcare's broader hospital ecosystem.

Name

Agilus Diagnostics

Legal name

Agilus Diagnostics Ltd.

Website

https://agilusdiagnostics.com

Company type

Private

Founded year

1995

Operating status

Operating

Short description

Agilus Diagnostics, a Fortis Healthcare subsidiary, operates India's largest diagnostic laboratory network (413 labs across 30+ states) offering 3,600+ pathology and radiology tests via walk-in, home collection, and digital channels.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)

Keywords

• Diagnostic laboratory services
• Pathology and radiology testing
• Health checkup packages
• Molecular diagnostics and genomics
• Home sample collection

Headquarters

HQ city

Mohali

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Testing Services (Fee-for-Service): Patients and healthcare providers pay per individual test or package. The company offers over 3,600 routine and specialized tests. Revenue is generated on a transactional basis from walk-in patients, home collection bookings, hospital referrals, and corporate/health check clients. No subscription model is described; pricing is per test or package with discounts available (e.g., 7% off on CBC).

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

Agilus Diagnostics provides diagnostic laboratory and radiology testing services across India through a network of 413 accredited labs and home sample collection. The company's core offering spans 3,600+ routine and specialized pathology tests, molecular diagnostics and genomics, advanced imaging, and preventive health checkup packages sold directly to consumers, hospitals, and corporate clients. Services are delivered through physical labs, a phlebotomist-driven home collection network, and digital booking channels (website, mobile app, WhatsApp).

Product overview

Agilus Diagnostics is India's largest diagnostic company by number of laboratories, operating 413 networking labs across 30+ states. Formerly known as SRL Diagnostics (renamed in 2023), the company offers a comprehensive diagnostic platform with 3,600+ routine and specialized tests spanning pathology, radiology, molecular diagnostics, genetics, and immunology. The portfolio includes core Agilus Diagnostics brand services, Agilus Care Packages (Vital Care, Active Care, Premium Care), health imaging services (Ultrasound, X-Ray, ECG, Mammography), and specialized offerings like molecular diagnostics and genetics. The company operates subsidiaries including Agilus Pathlabs Private Limited and DDRC Agilus Pathlabs, and provides digital access through its mobile app and eDOS test directory. Services are delivered through both walk-in labs and home collection options.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostic Pathology and Radiology Tests Comprehensive routine and specialized pathology and radiology testing services including CBC, HbA1c, lipid profile, kidney and liver function tests, thyroid panels, infectious disease tests, and specialty assays, delivered through 413 accredited labs across India for individual patients, hospitals, and healthcare providers.
• Agilus Care Health Checkup Packages Pre-defined health checkup packages including Vital Care, Active Care, Active Pro, Premium Care, Diabetes & Heart Care, Vital Shape, Student Care, and Pre Marriage Care, offering comprehensive screening covering 90+ parameters for individual consumers and corporate wellness clients.
• Molecular Diagnostics and Genetic Testing

Quantifiable outcome

• Routine test results typically available within 24 hours
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered minor and core.

• Agilus Pathlabs Private LimitedminorOthers · 5 August 2026Intra-group restructuring where Agilus Diagnostics Limited (parent) approved the merger of its wholly owned subsidiary Agilus Pathlabs Private Limited into itself, pending NCLT and creditor approvals. DDRC Agilus Pathlabs Limited is also being merged into Agilus Diagnostics.
• DDRC Agilus Pathlabs LimitedminorOthers · 5 August 2026Intra-group restructuring where Agilus Diagnostics Limited (parent) approved the merger of its wholly owned subsidiary DDRC Agilus Pathlabs Limited into itself, pending NCLT and creditor approvals. Streamlines operations within the diagnostics segment without financial consideration.
• IlluminacoreTechnology or Integration · 29 January 2026Agilus Diagnostics installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory to expand India's next-generation sequencing capacity. The deployment enhances high-throughput genomic and multi-omic analysis capabilities for early disease detection and personalized treatment planning across clinical applications.
• LucencecoreTechnology or Integration · 25 February 2025Agilus Diagnostics and Lucence announced a strategic collaboration to integrate Lucence's molecular testing technologies into Agilus' laboratory network in India. The partnership enables Agilus to offer liquid biopsy-based screening for early cancer detection, recurrence monitoring, and therapy personalisation using Lucence's LiquidHALLMARK technology, expanding Agilus's advanced oncology offerings.
• Fortis HealthcarecoreOthersAgilus Diagnostics is a wholly owned subsidiary of Fortis Healthcare. The diagnostic services are integrated into Fortis Healthcare's hospital operations across India, serving as the primary diagnostic laboratory partner for Fortis facilities. Fortis Healthcare is listed on Indian exchanges and is majority-owned by Malaysia's IHH Healthcare.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Thyrocare Technologies: Asset-light Indian diagnostics chain (acquired by PharmEasy) operating a centralized hub-and-spoke model. Comparable to Agilus in B2B preventive wellness category but competes on cost via a fundamentally different operating model.
• Apollo Diagnostics: Diagnostics arm of Apollo Hospitals, offering pathology, imaging, and home collection services. Direct peer to Agilus on hospital-anchored demand, full-service diagnostics, and integrated patient funnel.
• Dr. Lal PathLabs: India's largest listed diagnostics chain by market cap, offering routine and specialized pathology across a pan-India network of labs and collection centers. Closely comparable to Agilus in customer base, test menu breadth, NABL accreditation, and B2B hospital referral model.
• Metropolis Healthcare: Listed Indian diagnostics chain with extensive lab and service network across India and Africa, offering pathology and wellness testing. Directly comparable to Agilus on service mix, B2B/B2C hybrid model, and NABL-accredited laboratory footprint.

Emerging players

• Tata 1mg (Diagnostics): Digital-first health platform offering diagnostics booking, e-pharmacy, and teleconsultation. Comparable to Agilus on consumer-facing test booking, but operates asset-light aggregator model rather than owned labs.
• Neuberg Diagnostics: Pan-India diagnostics chain focused on advanced molecular and specialty testing. Comparable to Agilus in NGS/genomics expansion and NABL-accredited operations, but smaller scale.
• Orange Health Labs: Tech-enabled on-demand diagnostics startup offering home sample collection with rapid turnaround in major Indian metros. Competes with Agilus on home collection convenience and digital UX, despite smaller scale.

Regional players

• Vijaya Diagnostic Centre: South India-focused diagnostics chain with strong presence in Telangana and Andhra Pradesh. Comparable in service breadth and B2C health checkup packages, but with smaller national footprint than Agilus.
• Suburban Diagnostics: Western India (Maharashtra)-focused diagnostics chain with strong pathology and preventive health packages. Comparable to Agilus in regional B2C health checkup category and home collection model.

Broad incumbents

• Siemens Healthineers: Global medical technology leader supplying IVD analyzers, laboratory diagnostics equipment, and digital health platforms. Broadly comparable as a strategic partner/enabler in the diagnostics ecosystem in which Agilus operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/agilusdiagnostics

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agilus Diagnostics